More on CORT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $83.25 |
|
|||
| Open | $82.91 | ||||
| 52 Wk High | $10.00 | ||||
| 52 Wk Low | $3.22 | ||||
| Day High | $84.35 | ||||
| Day Low | $82.40 | ||||
| P/E | N/A | ||||
| EPS | $-0.46 | ||||
| Volume | 83,799 | ||||
- Corcept reports improved diabetes outcomes with Korlym and GLP-1 combo
- Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®
- Form 4 CORCEPT THERAPEUTICS For: Jun 02 Filed by: Guyer William
- Form 4 CORCEPT THERAPEUTICS For: Jun 01 Filed by: Lyon Joseph Douglas
- Form 4 CORCEPT THERAPEUTICS For: Jun 01 Filed by: Guyer William
- Form 4 CORCEPT THERAPEUTICS For: Jun 01 Filed by: Maduck Sean
- Form 4 CORCEPT THERAPEUTICS For: Jun 01 Filed by: Mokari Atabak
- Form 4 CORCEPT THERAPEUTICS For: Jun 01 Filed by: Robb Gary Charles
- Form 8-K CORCEPT THERAPEUTICS For: May 19
- Form 4 CORCEPT THERAPEUTICS For: May 29 Filed by: BELANOFF JOSEPH K
Entities mentioned with CORT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
